Network abnormalities among non-manifesting Parkinson disease related LRRK2 mutation carriers

被引:11
|
作者
Jacob, Yael [1 ,2 ,3 ]
Rosenberg-Katz, Keren [3 ]
Gurevich, Tanya [3 ,4 ,5 ]
Helmich, Rick C. [6 ,7 ,8 ]
Bloem, Bastiaan R. [6 ,7 ,8 ]
Orr-Urtreger, Avi [5 ,9 ]
Giladi, Nir [3 ,4 ,5 ]
Mirelman, Anat [3 ,4 ,5 ,10 ]
Hendler, Talma [2 ,3 ]
Thaler, Avner [3 ,4 ,5 ]
机构
[1] Mt Sinai Med Ctr, Icahn Sch Med, Translat & Mol Imaging Inst, New York, NY 10029 USA
[2] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
[3] Tel Aviv Med Ctr & Sch Med, Sagol Brain Inst, Tel Aviv, Israel
[4] Tel Aviv Med Ctr & Sch Med, Neurol Inst, Movement Disorders Unit, Tel Aviv, Israel
[5] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[6] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen, Netherlands
[8] Radboud Univ Nijmegen, Med Ctr, Parkinson Ctr, Nijmegen, Netherlands
[9] Tel Aviv Med Ctr & Sch Med, Genet Inst, Tel Aviv, Israel
[10] Tel Aviv Med Ctr & Sch Med, Neurol Inst, Lab Early Markers Neurodegenerat, Tel Aviv, Israel
关键词
graph theory network analysis; LRRK2; machine learning classification; Parkinson's disease; resting state fMRI; DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; STRIATAL CONNECTIVITY; COGNITIVE PERFORMANCE; RESTING-STATE; BRAIN; REORGANIZATION; INDIVIDUALS;
D O I
10.1002/hbm.24543
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Non-manifesting carriers (NMC) of the G2019S mutation in the LRRK2 gene represent an "at risk" group for future development of Parkinson's disease (PD) and have demonstrated task related fMRI changes. However, resting-state networks have received less research focus, thus this study aimed to assess the integrity of the motor, default mode (DMN), salience (SAL), and dorsal attention (DAN) networks among this unique population by using two different connectivity measures: interregional functional connectivity analysis and Dependency network analysis (D(EP)NA). Machine learning classification methods were used to distinguish connectivity between the two groups of participants. Forty-four NMC and 41 non-manifesting non-carriers (NMNC) participated in this study; while no behavioral differences on standard questionnaires could be detected, NMC demonstrated lower connectivity measures in the DMN, SAL, and DAN compared to NMNC but not in the motor network. Significant correlations between NMC connectivity measures in the SAL and attention were identified. Machine learning classification separated NMC from NMNC with an accuracy rate above 0.8. Reduced integrity of non-motor networks was detected among NMC of the G2019S mutation in the LRRK2 gene prior to identifiable changes in connectivity of the motor network, indicating significant non-motor cerebral changes among populations "at risk" for future development of PD.
引用
下载
收藏
页码:2546 / 2555
页数:10
相关论文
共 50 条
  • [31] Merging global cohorts of manifesting and non-manifesting carriers of pathogenic variants in known Parkinson's disease genes
    Roopnarain, K.
    Vollstedt, E.
    Lange, L.
    Padmanabhan, S.
    Blauwendraat, C.
    Singleton, A.
    Katja, K.
    Klein, C.
    MOVEMENT DISORDERS, 2022, 37 : S575 - S575
  • [32] Olfactory dysfunction in sporadic Parkinson's Disease and LRRK2 carriers
    Johansen, K. K.
    Waro, B. J.
    Aasly, J. O.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 (05): : 300 - 306
  • [33] Deep brain stimulation outcome in parkin, LRRK2, and glucocerebrosidase mutation carriers and non-carriers in early onset Parkinson's disease
    Haddleston, D. E.
    Tang, M.
    Alcalay, R. N.
    Mejia-Santana, H.
    Cote, L.
    Clark, L.
    Ford, B.
    Marder, K.
    MOVEMENT DISORDERS, 2010, 25 (07) : S474 - S475
  • [34] LRRK2 mutations in Parkinson disease
    Farrer, M
    Stone, J
    Mata, IF
    Lincoln, S
    Kachergus, J
    Hulihan, M
    Strain, KJ
    Maraganore, DM
    NEUROLOGY, 2005, 65 (05) : 738 - 740
  • [35] Increased cancer risk in young LRRK2 mutation carriers compared to sporadic Parkinson's disease patients
    Waro, B. J.
    Karaliute, M.
    Aasly, J. O.
    MOVEMENT DISORDERS, 2014, 29 : S395 - S395
  • [36] Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson's disease
    Ichinose, Hiroshi
    Inoue, Ken-ichi
    Arakawa, Shinobu
    Watanabe, Yuki
    Kurosaki, Hiroki
    Koshiba, Shoko
    Hustad, Eldbjorg
    Takada, Masahiko
    Aasly, Jan O.
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (01) : 45 - 52
  • [37] Increased dopamine turnover: A possible contributor to the increased risk of Parkinson's disease in LRRK2 mutation carriers
    Sossi, V.
    Nandhagopal, R.
    Wile, D.
    Schulzer, M.
    McKenzie, J.
    Dinelle, K.
    Farrer, M.
    Wszolek, Z. K.
    Aasly, J.
    Stoessl, A. J.
    MOVEMENT DISORDERS, 2015, 30 : S24 - S25
  • [38] Resistance to Parkinson's disease among LRRK2 mutation carriers is associated with higher plasma levels of urate but not its purine precursors
    Schwarzschild, M.
    Bakshi, R.
    Logan, R.
    Zorlu, M.
    Chen, X.
    Ascherio, A.
    Macklin, E.
    MOVEMENT DISORDERS, 2018, 33 : S606 - S606
  • [39] Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson’s disease
    Hiroshi Ichinose
    Ken-ichi Inoue
    Shinobu Arakawa
    Yuki Watanabe
    Hiroki Kurosaki
    Shoko Koshiba
    Eldbjorg Hustad
    Masahiko Takada
    Jan O. Aasly
    Journal of Neural Transmission, 2018, 125 : 45 - 52
  • [40] Autonomic dysfunction in parkinsonian LRRK2 mutation carriers
    Tijero, Beatriz
    Gomez Esteban, Juan Carlos
    Somme, Johanne
    Llorens, Veronica
    Lezcano, Elena
    Martinez, Ana
    Rodriguez, Trinidad
    Berganzo, Koldo
    Jose Zarranz, Juan
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (10) : 906 - 909